Company Profile for MIICRO, Inc.Business Editors --(BUSINESS WIRE) MIICRO is dedicated to the application of neuroimaging technology to accelerate and improve the discovery and development of drugs affecting the Central Nervous System (CNS See Continuous net settlement. CNS See continuous net settlement (CNS). ). MIICRO has developed methods utilizing positron emission tomography positron emission tomography: see PET scan. positron emission tomography (PET) Imaging technique used in diagnosis and biomedical research. (PET) imaging, in combination with cognitive and behavioral behavioral pertaining to behavior. behavioral disorders see vice. behavioral seizure see psychomotor seizure. measures, as a powerful means to elucidate e·lu·ci·date v. e·lu·ci·dat·ed, e·lu·ci·dat·ing, e·lu·ci·dates v.tr. To make clear or plain, especially by explanation; clarify. v.intr. To give an explanation that serves to clarify. the effects of pharmaceutical compounds on the CNS. Qualitative and quantitative insight can be gained into critical questions throughout all phases of clinical development, as well as in preclinical preclinical /pre·clin·i·cal/ (-klin´i-k'l) before a disease becomes clinically recognizable. pre·clin·i·cal adj. 1. development.
Company: MIICRO, Inc.
Headquarters Address: 322 S. Green St.
Suite 202
Chicago, Illinois 60607
Main Telephone: 312-602-5500
Website: www.miicro.com
Type of Organization: Private
Industry: Health: Biotechnology
Key Executives: President and CEO: Dawn Matthews
EVP of Operations: Terry Brown
Investor Relations
Contact: Jodi Flax
Phone: 312-602-5531
Email: jflax@miicro.com
Public Relations
Contact: Jodi Flax
Phone: 312-602-5531
Email: jflax@miicro.com
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion